4.6 Article

Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation

Journal

TRANSPLANTATION
Volume 100, Issue 8, Pages 1699-1704

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0000000000001204

Keywords

-

Ask authors/readers for more resources

Background. Donation after circulatory death (DCD) donor pool remains underutilized for liver transplantation (LT). We describe optimizing modifiable risk factors, such as cold ischemia time (CIT) recipient warm ischemia time (WIT) and the use of thrombolytic flush at the time of procurement to minimize ischemic cholangiopathy (IC). Methods. From July 2011 (era II), to improve outcomes after DCD LT, measures were taken to minimize CIT, operative time and recipient WIT along with the use of tissue plasminogen activator (tPA) flush during DCD procurements. Thirty consecutive DCD LTs were performed prospectively in era II. Outcomes were compared with 61 historic controls (era I). Reperfusion biopsies were evaluated for the presence of necrosis and biliary epithelial damage. Results. Median CIT (4.9 [3.5-5.9] vs 6.4 [4.3-12]; P < 0.001), hepatectomy time (70 [42-120] vs 81 [58-207]; P = 0.02), and recipient WIT (16 [13-31] vs 24[15-40]; P < 0.001) were significantly shorter in era II. All patients in era II received tPA flushed liver grafts. None of the patients in era II developed IC (0% vs 18%; P = 0.013). There were fewer biliary complications in era II, and there was no increased risk of bleeding associated with the use of tPA. One-year graft survival was slightly better in era II (n = 24 patients with 1 year follow-up) (88% vs 80%; P = 0.14). Conclusions. Optimizing peritransplant conditions, such as shortening ischemic times with the use of thrombolytic donor flush, may prevent IC after DCD LT. With this approach, the DCD donor pool may be expanded.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Impact of the acuity circle model for liver allocation on multivisceral transplant candidates

Tommy Ivanics, Rodrigo Vianna, Chandrashekhar A. Kubal, Kishore R. Iyer, George Mazariegos, Cal S. Matsumoto, Richard Mangus, Thiago Beduschi, Marwan Abouljoud, Jonathan A. Fridell, Shunji Nagai

Summary: The update in liver allocation from DSA to AC had varying impacts on waitlist mortality and transplant probability for patients listed for combined liver-intestine transplantation, with lower transplant probability observed in adults but similar outcomes in pediatric patients. Additionally, there was a decrease in the proportion of patients who underwent transplant with exception points post-AC. Efforts should be made to ensure equitable organ allocation in this vulnerable patient population.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States

Marwan Ghabril, Jiayi Ma, Kavish R. Patidar, Lauren Nephew, Archita P. Desai, Eric S. Orman, Raj Vuppalanchi, Shekhar Kubal, Naga Chalasani

Summary: Over the past quarter century, there have been significant changes in the trends of drug-induced acute liver failure (DIALF) in the United States, including shifts in patient demographics, changes in implicated agents, and notably improved post-liver transplantation survival rates for patients with DIALF.

LIVER TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation

Kawthar A. Mohamed, Marwan Ghabril, Archita Desai, Eric Orman, Kavish R. Patidar, John Holden, Susan Rawl, Naga Chalasani, Chandra Shekhar Kubal, Lauren D. Nephew

Summary: This study aimed to investigate the impact of race, gender, rural versus urban residence, and neighborhood socioeconomic indicators on liver transplantation waitlisting and death during the evaluation period. The results showed an association between neighborhood poverty and waitlisting as well as death during LT evaluation.

LIVER TRANSPLANTATION (2022)

Letter Immunology

Organoid Technology: Are Human Cholangiocyte Organoids Immune Protected?

Burcin Ekser, Wenjun Zhang, Ping Li, Heather Francis, Gianfranco Alpini

TRANSPLANTATION (2022)

Article Immunology

Clinical Aspect of Cytokines and Chemokines in Liver Transplant

Plamen Mihaylov, Burcin Ekser, Jonathan Fridell, Shekhar Kubal

Summary: This study investigates the release of proinflammatory cytokines and chemokines after liver transplantation and their relationship with ischemic reperfusion injury and acute kidney injury. The study finds that there is a certain pattern of expression for various cytokines and chemokines in all patients with ischemic reperfusion injury. Cold ischemia, macrosteatosis, postreperfusion syndrome, and the use of multiple vasoactive agents are identified as independent risk factors for ischemic reperfusion injury. The findings suggest that these immune cytokine signatures can be used for therapeutic interventions to improve post-transplant graft outcomes.

TRANSPLANTATION PROCEEDINGS (2022)

Article Oncology

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development

Ludovica Ceci, Tianhao Zhou, Ilaria Lenci, Vik Meadows, Lindsey Kennedy, Ping Li, Burcin Ekser, Martina Milana, Wenjun Zhang, Chaodong Wu, Keisaku Sato, Sanjukta Chakraborty, Shannon S. Glaser, Heather Francis, Gianfranco Alpini, Leonardo Baiocchi

Summary: This review provides an overview of the research progress on the risk factors and mechanisms of cholangiocarcinoma. These studies contribute to understanding the etiology and treatment options for cholangiocarcinoma.

CANCERS (2022)

Article Gastroenterology & Hepatology

Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis

Vik Meadows, Corinn Marakovits, Burcin Ekser, Debjyoti Kundu, Tianhao Zhou, Konstantina Kyritsi, Linh Pham, Lixian Chen, Lindsey Kennedy, Ludovica Ceci, Nan Wu, Guido Carpino, Wenjun Zhang, Abdulkadir Isidan, Alison Meyer, Travis Owen, Eugenio Gaudio, Paolo Onori, Gianfranco Alpini, Heather Francis

Summary: Primary sclerosing cholangitis (PSC) is characterized by increased ductular reaction, liver fibrosis, hepatic total bile acid levels, and mast cell infiltration. Inhibition of apical sodium bile acid transporter (ASBT) reduces PSC phenotypes. This study evaluates the role of ASBT in PSC and has clinical significance.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2023)

Article Pathology

Development of Scaffold-Free Three-Dimensional Cholangiocyte Organoids to Study the Progression of Primary Sclerosing Cholangitis

Wenjun Zhang, Konstantina Kyritsi, Abdulkadir Isidan, Yujin Park, Ping Li, Arthur A. Cross-Naja, Kevin Lopez, Lindsey Kennedy, Keisaku Sato, Shannon Glaser, Heather Francis, Gianfranco Alpini, Burcin Ekser

Summary: Researchers have developed a scaffold-free multicellular three-dimensional cholangiocyte organoid model to study the pathophysiology of primary sclerosing cholangitis (PSC). This model effectively mimics the phenotypic features of PSC patients and can be used for related research.

AMERICAN JOURNAL OF PATHOLOGY (2023)

Review Surgery

Impact of gut microbiota on liver transplantation

Serkan Sucu, Kerem E. Basarir, Plamen Mihaylov, Emre Balik, Jason T. C. Lee, Jonathan A. Fridell, Juliet A. Emamaullee, Burcin Ekser

Summary: The gut microbiota is closely related to liver transplantation, and dysbiosis, antibiotic use, surgical stress, and immunosuppressive drugs can all affect the success of liver transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Letter Gastroenterology & Hepatology

Letter to the Editor: Mucosal gut microbiota in primary sclerosing cholangitis before and after liver transplantation-Are there other challenges?

Burcin Ekser, Serkan Sucu, Plamen Mihaylov, Juliet A. Emamaullee

HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

Postliver transplant acute cardiomyopathy: Role of prospective cardiac evaluation in immediate posttransplant period

Zachary P. Rokop, Joseph Zenisek, Kyle Frick, Richard S. Mangus, Lava Timsina, Elizabeth Kroepfl, Chandrashekhar Kubal

LIVER TRANSPLANTATION (2023)

Article Endocrinology & Metabolism

ATG14 plays a critical role in hepatic lipid droplet homeostasis

Menghao Huang, Yang Zhang, Jimin Park, Kushan Chowdhury, Jiazhi Xu, Alex Lu, Lu Wang, Wenjun Zhang, Burcin Ekser, Liqing Yu, X. Charlie Dong

Summary: This study reveals that ATG14 is localized to lipid droplets in hepatocytes, and it enhances lipid droplet breakdown through interactions with adipose triglyceride lipase (ATGL) and CGI-58.

METABOLISM-CLINICAL AND EXPERIMENTAL (2023)

Article Surgery

Severe hepatic encephalopathy with mechanical ventilation may inform waitlist priority in acute liver failure: A UNOS database analysis

Jiayi Ma, James E. Slaven, Lauren Nephew, Kavish R. Patidar, Archita P. Desai, Eric Orman, Chandrashekhar Kubal, Naga Chalasani, Marwan Ghabril

Summary: The study found that cumulative organ failure, especially neurologic and respiratory failure, significantly impacts waitlist and post-LT mortality in patients with ALF, which may inform risk-prioritized allocation of organs.

CLINICAL TRANSPLANTATION (2023)

Article Cell Biology

Porcine UL-16 Binding Protein 1 Is Not a Functional Ligand for the Human Natural Killer Cell Activating Receptor NKG2D

Kevin J. Lopez, John Paul Spence, Wei Li, Wenjun Zhang, Barry Wei, Arthur A. Cross-Najafi, James R. Butler, David K. C. Cooper, Burcin Ekser, Ping Li

Summary: This study clarifies the role of pULBP-1 in the interaction between NK cells and pig cells. The results demonstrate that pULBP-1 is not a crucial factor in initiating xenogeneic human NK cell activation.

CELLS (2023)

No Data Available